Read + Share
Tang M, Lee CK, Lewis CR, Boyer M, et al. Generalizability of immune checkpoint inhibitor trials to real-world patients
with advanced non-small cell lung cancer. Lung Cancer 2022;166:40-48.
PMID: 35152172
|
 |
|
Tang M, Lee CK, Lewis CR, Boyer M, et al. Generalizability of immune checkpoint inhibitor trials to real-world patients
with advanced non-small cell lung cancer. Lung Cancer 2022;166:40-48.
PMID: 35152172
|
|
|
|